Biotech Values

[theordore]

I was referring to IV, and I am happy to report that no poster there supports Gliead discussion of M&A prospects. My reading of a rather long thread there is that the posters generally see no need for Gilead to be 'anxious' to do M&A. If we are looking at an already great biotech company, in terms of its world-wide contributions, management has no need to be concerned about 'pushing' the stock price with exciting news on the M&A front.